CERE DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors with Losses in Excess of

  • NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / WHY: New York, N.Y., May 28, 2025.